Detalhe da pesquisa
1.
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.
Lancet
; 397(10287): 1809-1818, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33964223
2.
Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial.
Lancet Infect Dis
; 22(12): 1728-1736, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087586